Lista de obras - Jerome Moreaux - Dominio Público Uruguay

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy

artículo científico publicado en 2014

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

artículo científico publicado en 2020

APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

artículo científico publicado en 2009

An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy.

artículo científico publicado en 2018

Analysis of Global Gene Expression Profiles

artículo científico publicado en 2018

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

artículo científico publicado en 2019

Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.

artículo científico publicado en 2017

BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma

scientific article published on 12 November 2018

CD200: a putative therapeutic target in cancer

artículo científico publicado en 2007

Characterization of human FCRL4-positive B cells

artículo científico publicado en 2017

Clinical and prognostic role of annexin A2 in multiple myeloma.

artículo científico publicado en 2012

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance

artículo científico publicado en 2019

Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.

artículo científico publicado en 2012

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

artículo científico publicado en 2020

DNA repair in diffuse large B-cell lymphoma: a molecular portrait

artículo científico publicado en 2014

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.

artículo científico publicado en 2018

Differential effects of lenalidomide during plasma cell differentiation

artículo científico publicado en 2016

EZH2 in normal hematopoiesis and hematological malignancies

artículo científico publicado en 2016

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation

scientific article published on 12 February 2019

Embryonic stem cell markers expression in cancers.

artículo científico publicado en 2009

Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia

artículo científico publicado en 2015

Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

artículo científico publicado en 2017

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma

artículo científico publicado en 2015

Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.

artículo científico publicado en 2013

Hypoxia favors the generation of human plasma cells

artículo científico publicado en 2017

Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum

artículo científico publicado en 2014

Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.

artículo científico publicado en 2014

Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.

artículo científico publicado en 2016

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

scientific article published on 20 January 2019

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.

artículo científico publicado en 2015

Induction of angiogenesis by normal and malignant plasma cells.

artículo científico publicado en 2009

Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related () Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer

artículo científico publicado en 2019

Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.

artículo científico publicado en 2007

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

artículo científico publicado en 2019

Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression.

artículo científico publicado en 2017

Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.

artículo científico publicado en 2005

MMSET is overexpressed in cancers: link with tumor aggressiveness

artículo científico publicado en 2008

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

scientific article published on 18 November 2019

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

artículo científico publicado en 2018

NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm

scientific article published on 01 April 2010

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

artículo científico publicado en 2010

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner

scientific article published on 22 February 2019

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

article

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact

scientific article published on 22 July 2019

Physiological and druggable skipping of immunoglobulin variable exons in plasma cells

scientific article published on 20 August 2018

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

scientific article published on 26 June 2019

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value

artículo científico publicado en 2016

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

artículo científico publicado en 2017

Role of Polycomb Complexes in Normal and Malignant Plasma Cells

scientific article published on 28 October 2020

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma.

artículo científico publicado en 2014

SULFs in human neoplasia: implication as progression and prognosis factors.

artículo científico publicado en 2011

TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.

artículo científico publicado en 2007

The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

scientific article published on 15 May 2019

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation

artículo científico publicado en 2019

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

artículo científico publicado en 2005

The role of fluorescence in situ hybridization and gene expression profiling in myeloma risk stratification.

artículo científico publicado en 2011

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

scientific article published on 18 September 2019

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients.

artículo científico publicado en 2018

[CD38 antibodies in multiple myeloma]

scientific article published on 01 December 2019

[EZH2 is therapeutic target for personalized treatment in multiple myeloma]

scientific article published on 02 July 2018

Lista de obras de Jerome Moreaux

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy

A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment

APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy.

Analysis of Global Gene Expression Profiles

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.

BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma

CD200: a putative therapeutic target in cancer

Characterization of human FCRL4-positive B cells

Clinical and prognostic role of annexin A2 in multiple myeloma.

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance

Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

DNA repair in diffuse large B-cell lymphoma: a molecular portrait

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.

Differential effects of lenalidomide during plasma cell differentiation

EZH2 in normal hematopoiesis and hematological malignancies

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation

Embryonic stem cell markers expression in cancers.

Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia

Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma

Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.

Hypoxia favors the generation of human plasma cells

Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum

Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.

Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.

Induction of angiogenesis by normal and malignant plasma cells.

Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related () Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer

Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression.

Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.

MMSET is overexpressed in cancers: link with tumor aggressiveness

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact

Physiological and druggable skipping of immunoglobulin variable exons in plasma cells

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

Role of Polycomb Complexes in Normal and Malignant Plasma Cells

SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma.

SULFs in human neoplasia: implication as progression and prognosis factors.

TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.

The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

The role of fluorescence in situ hybridization and gene expression profiling in myeloma risk stratification.

Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients.

[CD38 antibodies in multiple myeloma]

[EZH2 is therapeutic target for personalized treatment in multiple myeloma]